Delivery Order SPE2DB22D2206-SPE2DB25FJH44
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,676.05 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 8 mg tablets (30-count package), a generic medication primarily used to treat Parkinson's disease and restless leg syndrome. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The award date of July 29, 2025, with an ultimate completion date of July 30, 2025, reflects the expedited nature of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,373.64 Firm Fixed Price delivery order is for the supply of Ropinirole HCL ER 6 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $55,190 to Amerisourcebergen Drug Corporation for the supply of 100 units of 0.25 mg Ropinirole HCl tablets. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is funded through DLA and runs from July 13, 2023 through July 14, 2023 to support DOD's medical supply needs. As a leading provider of pharmaceuticals and healthcare value-added...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $836.96 to Amerisourcebergen Drug Corp for the supply of 90 Ropinirole HCL ER 2 mg tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning August 2nd and concluding on August 3rd, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 12 mg tablets, with a ceiling value of $1,536.03 and a completion date of January 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a $26,574.99 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562019249 Ropinirole HCL ER 12 mg tablets, 30 count. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 31, 2023 through September 1, 2023 to fulfill the Defense Logistics Agency's requirements for this pharmaceutical product in...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has a ceiling value of $1,668.36 and an ultimate completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency Troop Support Medical awarded a $63,750 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of 2 mg ropinirole hydrochloride tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 31, 2023 through September 1, 2023. This delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply...
- This federal contract award, valued at $1,570.56, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJH44Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,172.67 to AmerisourceBergen Drug Corp for Ropinirole HCL ER 2 mg tablets (90-count supply). This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal medical procurement operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. Ropinirole HCL ER is a dopamine agonist commonly used in the treatment of Parkinson's disease and restless leg syndrome, reflecting the company's role in supplying specialized neurological treatments alongside its broader pharmaceutical portfolio to federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/8/25 |